Tscan TherapeuticsTCRX
13F holders, Q1 2026 (March 31)60holders −1
8new positions
10sold out
4famous investors
$1.01avg. 13F price*
At the end of Q1 2026, 60 institutions reported holding Tscan Therapeutics Inc. (TCRX) in their 13F filings, down 1 from Q4 2025. 8 opened new positions and 10 sold out. The largest holders were Lynx1 Capital Management LP ($8.1M), BVF Inc. ($5.6M) and Baker Bros. Advisors LP ($2.8M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Tscan Therapeutics Inc.
- CUSIP
- 89854M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $340K |
| Exits | 10 | $157K |
All 13F filers, Q4 2025 → Q1 2026: 3,954,365 shares bought and 1,790,495 shares sold, net +2,163,870 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 60 holders
| Lynx1 Capital Management LP | 1.28% | No change | 8,019,148 | $8.1M |
| BVF Inc. | 0.18% | Add +6.5% | 5,564,290 | $5.6M |
| Baker Bros. Advisors LP | 0.02% | No change | 2,784,792 | $2.8M |
| Vanguard Capital Management LLC | 0.00% | — | 2,154,256 | $2.2M |
| BlackRock, Inc. | 0.00% | Reduce -0.4% | 1,840,952 | $1.9M |
| Millennium Management | 0.00% | Add +261.8% | 1,460,285 | $1.5M |
| Renaissance Technologies | 0.00% | Add +19.6% | 1,364,783 | $1.4M |
| Deer Management Co. LLC | 0.20% | No change | 1,245,504 | $1.3M |
| Two Sigma Investments, LP | 0.00% | Add +85.7% | 1,209,009 | $1.2M |
| Aberdeen Group plc | 0.00% | Reduce -48.6% | 918,020 | $927K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Add +329.6% | 808,356 | $816K |
| DC Funds, LP | 42.40% | No change | 630,000 | $630K |
| Geode Capital Management, LLC | 0.00% | Add +9.8% | 616,952 | $623K |
| Gsa Capital Partners LLP | 0.02% | Add +67.6% | 378,960 | $383K |
| D. E. Shaw & Co. | 0.00% | Add +360.3% | 319,587 | $323K |
| Citadel Advisors | 0.00% | Add +95.5% | 318,411 | $322K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 305,772 | $309K |
| Marshall Wace, LLP | 0.00% | Reduce -30.0% | 237,346 | $240K |
| State Street Corp. | 0.00% | No change | 207,313 | $209K |
| Acadian Asset Management LLC | 0.00% | Add +583.8% | 201,987 | $201K |
| Morgan Stanley | 0.00% | Reduce -23.1% | 173,643 | $175K |
| Susquehanna International Group, LLP | 0.00% | Reduce -27.3% | 157,228 | $159K |
| Jane Street Group, LLC | 0.00% | Reduce -62.8% | 144,421 | $146K |
| Brown Brothers Harriman & Co. | 0.00% | No change | 143,051 | $144K |
| Verdad Advisers, LP | 0.15% | New | 134,001 | $135K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -3.0% | 111,900 | $113K |
| Northern Trust Corp. | 0.00% | Reduce -0.8% | 97,448 | $98K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 95,875 | $97K |
| NewEdge Wealth, LLC | 0.00% | No change | 91,463 | $92K |
| Stifel Financial Corp. | 0.00% | Reduce -4.1% | 69,400 | $70K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -12.3% | 65,335 | $66K |
| Kestra Advisory Services, LLC | 0.00% | New | 62,525 | $63K |
| XTX Topco Ltd | 0.00% | Reduce -72.3% | 60,720 | $61K |
| Bank of America Corp. | 0.00% | Add +48.6% | 57,529 | $58K |
| Ameriprise Financial Inc. | 0.00% | New | 52,635 | $53K |
| NINE MASTS CAPITAL Ltd | 0.01% | New | 41,740 | $42K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -57.1% | 37,267 | $38K |
| DC Investments Management, LLC | 0.01% | No change | 35,563 | $36K |
| UBS Group AG | 0.00% | Reduce -41.1% | 32,484 | $33K |
| Prudential Financial Inc. | 0.00% | Add +22.1% | 29,800 | $30K |
| Panagora Asset Management Inc. | 0.00% | Add +14.0% | 28,797 | $29K |
| Public Employees Retirement System of Ohio | 0.00% | New | 27,700 | $28K |
| HSBC Holdings PLC | 0.00% | No change | 24,574 | $24K |
| LPL Financial LLC | 0.00% | No change | 22,500 | $23K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Add +45.5% | 21,359 | $22K |
| Virtu Financial LLC | 0.00% | New | 18,140 | $18K |
| Barclays PLC | 0.00% | Reduce -26.4% | 17,080 | $17K |
| Vanguard Global Advisers, LLC | 0.00% | — | 15,705 | $16K |
| JPMorgan Chase & Co. | 0.00% | Reduce -50.7% | 16,436 | $15K |
| Aries Wealth Management | 0.00% | No change | 10,000 | $10K |
| Osaic Holdings, Inc. | 0.00% | Reduce -20.3% | 9,756 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -25.2% | 5,063 | $5K |
| Federated Hermes, Inc. | 0.00% | Reduce -13.9% | 4,295 | $4K |
| FMR LLC | 0.00% | Add +160.0% | 1,300 | $1K |
| BNP Paribas Financial Markets | 0.00% | Reduce -97.3% | 713 | $720 |
| SBI Securities Co., Ltd. | 0.00% | No change | 392 | $396 |
| Strategic Wealth Partners, Ltd. | 0.00% | No change | 311 | $314 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 2 | $2 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -80.5% | 73 | $0 |
"% of holder's portfolio" is TCRX's weight in each manager's 13F, not the share of Tscan Therapeutics Inc. the manager owns.